Nordic symposium: Role of large middle molecues in chronic kidney disease
25-26 November, 16:00-18:00 CET
This symposium is entirely virtual in order to enable participants and speakers to safely attend due to the current COVID-19 situation.
During the symposium, our speakers will discuss current innovative therapies in hemodialysis, with a focus on the advancement of the medium cut off (MCO) membranes, as well as its implications in clinical and patient reported outcomes.
Approved by the Federation of the Royal College of Physicians UK for 4 external (category 1) CPD credit(s) for attendance at both symposium days (25th and 26th of November 2020).